Lymphocytes express two types of TCRs, either a/f (1-3) or y/b (4) . The genes encoding the TCR y and b chains are composed of V, D, J, and C regions that undergo somatic rearrangement during development (5, 6) . There are only eight functional Vy gene segments and perhaps 5-10 functional VS gene segments identified in humans (6) . While the specificity ofthe TCR-,y/b is poorly understood, the limited germline diversity suggested that TCR-y/b-bearing lymphocytes might recognize antigen in the context of relatively nonpolymorphic antigen-presenting molecules (6) . Recently, alloreactive TCR-, y/b cells specific for MHC class I and class II gene products, as well as class I-like gene products (Tla and Qa), have been described (7) (8) (9) . The distinct nature ofthe TCR-y/b, the fact that lymphocytes that bear it frequently lack CD4 and CD8, and the non-MHC-restricted recognition of tumor targets by some TCR-,y/b cells (10) , led us to suggest that these TCRs might recognize cell surface molecules not encoded in the MHC (10) . It was recently demonstrated that a human TCR-,y/b clone can recognize non-MHC-encoded CD1 antigens that might serve as novel antigen-presenting molecules for CD4 -8-T cells (11) . In addition, some of the specific antigens that y/b T cells can recognize have been identified, such as mycobacterial antigens (including heat-shock-proteins) (12) (13) (14) (15) (16) and tetanus toxoid (17) . TCR-,y/6' lymphocytes expand markedly in number in lymphoid organs and in tissue lesions in response to the mycobacterial antigens (13, 15) .
TCR-, y/b cells comprise ti5% (0.5-20%) of the CD3+ cells in human peripheral blood and in lymphoid tissues (18) (19) (20) . However, in mice, TCR-, y/b cells preferen-tially localize and constitute the predominant subset at epithelial surfaces, such as in the skin (dendritic epidermal cells [dEC]') (21) and in the intestine (intraepithelial lymphocytes [IEL] ) (22, 23) . dEC express a single Vy/Vb pair (Vy3/Vbl) and have very limited diversity at their V(D)J junctions, resulting in a population of T cells that express virtually identical receptors in this location (24) . In contrast, gut IEL express predominantly two different Vy/VS pairs (V75/V64 or Vy5/V66) and have much greater junctional diversity (23) . In the mouse thymus, Vy and VS gene rearrangements appear in a sequential order (25) . This ordered pattern in development may account for the nonrandom expression of specific pairs of Vy and VS gene segments observed at different anatomical sites. Alternatively, or in addition, various types of thymic selection, differential homing, or peripheral expansion might influence the V gene pairs utilized and their peripheral locations . The site-specific localization of y/b T cells bearing certain V gene pairs and the differences in diversity of the junctional regions has led to the hypothesis that each cell population might perform distinct functions related to their anatomical site.
In humans, the marked epithelial localization seen in the mouse has not been observed (18) . However, the relatively small percentage ofTCR'Y/b cells in gut were noted preferentially to localize to the epithelium rather than the lamina propria in one study (26) . Yet, selective Vy and VS gene pairing and differences in V gene usage at various anatomical sites have been observed in man . The Vy2/VS2 chain pair occurs in most individuals on >70% of the circulating y/b T cells (27, 28) . In contrast, VS1' cells are prevalent in late fetal and postnatal thymus and in the red pulp of spleen (28, 29) . To gain insight into the differential TCR y/b variable chain usage in thymus compared with peripheral blood, in this report, both thymic and extrathymic influences on the TCR-7/6 repertoire were studied. The results provide evidence that a marked extrathymic expansion of y/6 T cells bearing certain V gene segments occurs and is an important feature in determining the peripheral TCR-y/S repertoire in man .
Materials and Methods mAbs. mAbs used were SPVT3b (anti-CD3) (30) , antiTCR-S1 (pan-reactive antiTCRb) (31), 6TCSI (anti-V61-J61, which appears to represent the most frequent V61 rearrangement expressed in peripheral blood) (29, 32) , BB3 (anti-V62) (33, 34) , antiTiya (antiVy2 [also called Vy9, for nomenclature see reference 6]) (35) , anti-CyMl (pan-reactive antiTCR y) (36) , BMA 031 (pan-reactive antiTCR-a/O; kind gift of Dr. Kurrle at Behringwerke AG, Marburg, FRG), and UCHLI (anti-CD45RO) (37) . Isotype-matched mAbs that do not react with human leukocytes were used as controls .
In Vitro TranscriptionlTranslation. A truncated TCR-S insert was prepared from the IDP2 TCR S cDNA clone (38) containing sequences downstream of the FnuD II site at the codon encoding amino acid 106 in the D region . The truncated CS insert was ligated into the vector pSP73 downstream from the SP6 promoter to yield the pSP73.Cb. In this construct, the first methionine codon is at amino acid residue 138 within the constant region ofthe TCRS chain . Therefore, in vitro transcription and translation ofthis construct should yield a protein that only includes amino acids encoded by the CS gene segment. Constructs encoding the fulllength IDP2-b protein (pGEM3-0240/38) and the IDP2 y protein (pSP65 .IDP2y) have been ' Abbreviations used in this paper: CBL, umbilical cord blood lymphocytes; CBMC, cord blood mononuclear cells; dEC, dendritic epidermal cells; IEL, intraepithelial lymphocytes. described previously (31, 39) . These three cDNA constructs were linearized with appropriate restriction endonucleases, transcribed, and translated in vitro. The resulting protein products were then immunoprecipitated utilizing mAb anti-C-yM1, antiTCR-81, and an IgGI isotype-matched control antibody.
Immuno.luorescence Analysis ofCell Suspensions . Heparinized blood was obtained from umbilical cords of uncomplicated deliveries at the Brigham and Women's Hospital . Cord blood mononuclear cells (CBMC) were isolated by centrifugation at 1,340 g with 45% sepracell-MN (Sepratech, Oklahoma City, OK), 55% cord blood . When necessary, residual RBC were lysed with ammonium chloride (40) . PBMC from peripheral blood were isolated using FicollPaque (Pharmacia Fine Chemicals, Uppsala, Sweden) . Thymocyte suspensions were prepared by gently teasing thymic tissue into single cell suspensions using the entire lobule to ensure that cortical and medullary thymocytes were accurately represented . Tonsil-derived lymphocytes were prepared by gently teasing entire tonsil tissue into a single cell suspension. For single-color analysis thymocytes, PBMC, CBMC, or tonsillar lymphocytes were resuspended at 2-4 x 106 cells/ml in staining buffer (PBS/5% human serum/1% BSA/0.02% NaN3) containing saturating amounts of mAbs and incubated for 1 h at 4°C . After three washes with staining buffer, cells were incubated with FITC-labeled F(ab')2 goat anti-mouse Ig (Tago Inc., Burlingame, CA) . Two-color staining was performed using unconjugated mAbs followed by FITC-conjugated goat anti-mouse Ig, then followed by an incubation with saturating amounts of normal mouse serum. Biotin-conjugated mAbs followed by PE-conjugated streptavidin (Becton Dickinson & Co., Mountain View, CA, or Tago Inc.) were used as the second-step reagents. Labeled cells were analyzed with either a Facscan flow cytometer (Becton Dickinson & Co.) or Epics C (Coulter Electronics Inc., Hialeah, FL) .
T Cell Lines. PBMC from a normal donor were isolated by density gradient centrifugation with Ficoll-Paque (See above) . The PBMC were depleted of cdo T cells by incubation with antiTCR-a/(3 (BMA 031) followed by goat anti-mouse Ig-conjugated magnetic beads (M450 ; Dynal, Oslo, Norway) . Cells with attached beads were removed by adherence to a magnet . TCR a/l3-depleted lymphocytes were then enriched for TCR-y/b cells by incubation with the panreactive antiTCR-y/b antibody (antiTCR 61) followed by incubation with the goat anti-mouse Ig-conjugated magnetic beads and magnet selection . The y/6 T cell-enriched line was cultured with irradiated PBL feeder cells and maintained in culture by periodic restimulation with PHA as previously described (4) . After 4 wk ofculture, the cells in this line stained homogeneously with the pan-reactive TCR-y/b mAb ; 7.6% of the cells in this line stained with the V61-specific mAb and 93.5% stained with the V52-specific mAb . Positive selection with an anti-CD8 mAb (OKT8) and magnetic beads produced a homogeneously V61' cell line. In long-term culture, >99% of the lymphocytes in the OKT8-selected line were positive with the antiV61 mAb, and >99% ofthe lymphocytes in the original TCR y/b-enriched line were reactive with the anti-V62 mAb .
Results
Anti-7CR61 mAb Recognizes a Cb-encoded Determinant. Four mAbs directed against distinct TCRy/b determinants were utilized. mAb MCS1 detects a Vbljbl-encoded determinant (called anti-V61 in this study) (29, 32) , mAb BB3 (detects a V62-encoded determinant (antiV62) (33, 34) , and antiTiyA detects a Vy2-encoded determinant (antiVy2) (35) . In addition, mAb antiTCR-61 has broad reactivity against y/6 T cells and is thought to be panreactive . Here, a cDNA construct was transcribed and translated in vitro to produce a protein product including only the C region of the TCR6 protein, and this protein product was recognized by the antiTCR-61 mAb (Fig. 1 ). This demonstrates directly that the antiTCR-61 mAb recognizes a determinant in the Cb-encoded portion of the TCR 6 chain and thus should recognize all TCR-6-bearing lymphocytes (See Materials and Methods, and Fig. 1 ).
Age-related Changes in TCR-y/6 V Gene Usage in the Periphery. Seven umbilical cord blood samples and 27 thymi were analyzed for y/6 T cell number and variable chain AntiTCR61 recognizes a C6-encoded epitope. Anti TCR61 mAb immunoprecipitated the in vitro translated productwhose synthesis was directed by a full-length TCR6 construct (see TCR6 construct panel) . To determine if this mAb reacted with a determinant in the constant region of the S chain, in vitro transcription and translation of a truncated C6 construct was performed to produce a C region peptide. The antiTCR61 mAb immunoprecipitated this C region peptide (see C6 construct panel) . Isotypematched control mAb and anti-CyMl (antiTCR-y) mAb failed to recognize these 6 chain-encoded products . The antiTCR-y mAb did immunoprecipitate the protein product of theTCRy construct (see TCRy construct panel), while antiTCR61 did not immunoprecipitate the TCRy protein product. Thus, antiTCR-61 reacts specifically with a determinant encoded in the C6 region of the TCR6 protein, indicating that it should be reactive with all TCR-6-bearing T cells (see Materials and Methods for experimental details) .
usage. The TCR-y/6 V gene usage in cord blood and in thymus was quite similar, but differed from adult peripheral blood. Cord blood TCRy/S cells used predominantly V61-encoded products (50% of y/6 T cells) and less frequently expressed V62-encoded products (25% of y/S T cells) . Similarly, in the thymus, V61 expression was predominant as it was found on 65% of the y/6 T cells, while VS2 was expressed on only 10-15% of thymic y/S T cells. In contrast to thymus and cord blood, adult (>21 yr old) peripheral blood V gene usage was characterized by predominant expression of V62-encoded subunits (>70% of y/S T cells), while a smaller number of cells bore V61-encoded receptors (on <30% of y/6 T cells) in most individuals. In addition, the proportion of T cells expressing TCRy/S in cord blood was quite similar in all the individuals tested (mean of 1.73% [SEM = 0.18] of CD3`cells), and was on average threefold lower than the proportion of T cells expressing TCRy/6 in adult peripheral blood (5.7% [SEM = 1.4] of CD3+ cells) . These preliminary studies thus confirmed earlier reports (19, 20, 29) showing that a difference existed between y/S V gene usage in thymic and peripheral locations. Furthermore, the observation that peripheral umbilical cord blood at birth was similar to thymus, but distinct from adult peripheral blood suggested the existence of a significant age-related extrathymic expansion o£ circulating 'r/ 6 T cells associated with a change in the predominant V genes they expressed. This observation was examined in detail here.
The proportion of T cells expressing y/6 TCRs (antiTCR61 +) gradually rose from a mean of 1.73% of the T cells at birth, to a mean of 10% of the T cells at 6 yr of age, after which the mean fell to a lower level, with a wide range ofindividual values in adulthood ( Fig. 2 A, top) . Variable gene segment usage was analyzed in The lines on the plots were generated using a lowess smoother computer analysis (f = 0.5) (51). Percentage of cells positive for a given mAb was calculated using the formula: 100x (percent of PBL positive with mAb shown on they-axis/ percent of PBL positive with antiTCR-S1) .
these individuals by staining with anti-V61 and anti-V62 mAbs. During this time period, the proportion of T cells expressing Vbl remained nearly constant while the percentage of T cells expressing Vb2 increased strikingly (Fig. 2 A, middle and  bottom) . In addition to the age-related increase in the number of y/b T cells, a shift from a V61 predominance to a VS2 predominance over the first 6 yr of life was also observed (Fig. 2 B, top and bottom) . Thus, both the increase in cell number (Fig.  2 A) and the change in V gene predominance (Fig. 2 B) could be accounted for by an age-related expansion of the V62-bearing T cell subset .
V32 Expansion in the Periphery Occurs in the Absence of a Parallel Thymic Wave. Toaddress whether a postnatal thymic wave of TCR V62-expressing cells could explain the rising number ofV62-bearing cells in the periphery with advancing age, 29 thymi between 3 wk and 8 yr of age were examined by FACS staining for TCR y/b cell number and V gene segment expression. In addition, paired samples of peripheral blood were obtained at the same point in time from 18 of these individuals and analyzed for TCR-,y/b cell number and V gene segment expression . In contrast to the peripheral blood where an age-related increase in the proportion ofT cells expressing the TCR-y/b was observed ( Fig. 2 A, top) , in the thymus, the proportion of T cells expressing the TCR-y/b remained constant with increasing age, up to the age of 8 yr. This resulted in a rise in the ratio of T cells expressing TCRy/b in the peripheral blood compared with the thymus in the paired thymus/peripheral blood samples over time (Fig. 3 A) . In addition, thymus samples showed no change in the percentage of TCR--y/b cells bearing either Vbl-or V62-encoded receptors over time. In none of the thymi did we observe >30% Vb2+ cells (mean = 12%), including thymi from individuals in whom the Vb2 expansion (often to >85% of the y/b cells) had already occurred in the paired peripheral blood sample (Fig. 3 B) . Since the percentage of y/b T cells and usage of V gene segments was unchanged over time for all thymus samples examined, no evidence to support the occurrence of a postnatal thymic wave of V62-bearing cells was found. Instead, it seemed more likely that the expansion ofTCR -y/b cells bearing Vb2 in the periphery may have resulted from a postnatal extrathymic expansion of this subset, while the V61-bearing cells remained constant in number.
Age-related Expression of CD45RO on M52-bearing Cells. The CD45 transmembrane protein is found on all T cells and occurs in distinct isoforms as a result of alternatively spliced exons (41) . The smallest isoform, CD45RO, lacks all of the differentially spliced exons and is recognized by mAb UCHLI (42) . Nearly all T cells (>95%) from neonatal peripheral blood are negative or express only low levels of CD45RO (43, 44) . With increasing age, the percentage of T cells that express high levels of CD45RO rises until -60To of all of the circulating T cells are UCHLI h`in adulthood (43) . A similar rise has also been demonstrated for y/b T cells in peripheral blood (43) . To confirm that both Vbl + and Vb2 + y/b T cells were capable of expressing CD45RO after activation, in vitro cultured cell lines expressing these V genes were examined by FACS analysis ; which revealed that both expressed increased levels of CD45RO. The Vb2+ line expressed CD45RO at high levels, while Vbl cell lines expressed CD45RO at moderate levels. In addition, both Vb1-and V62-expressing thymocytes and tonsil-derived lymphocytes expressed moderate or high levels of CD45RO (data not shown) . 
T CELL RECEPTOR , y/b REPERTOIRE EXTRATHYMIC CHANGES
Since an increase in expression of CD45RO occurs when naive T cells are activated, this antigen may serve as a differentiation marker for previously activated or "memory" T cells (44, 45) . We therefore examined whether the expansion of V62-bearing cells observed here (Fig. 2 A, bottom) correlated with expansion of naive (CD45RO -or CD45RO10 ) or of previously activated (CD45ROh') cells. In umbilical cord blood lymphocytes (CBL), two populations of lymphocytes were observed, one that was unreactive (CD45RO-) and one that was weakly reactive (CD45RO'O) with UCHLI mAb (Fig . 4 A) . Very few (<5%) of neonatal T cells stained brightly with UCHLI. On PBL from children of increasing age, a third population of cells was observed that stained brightly (CD45ROh') . The CD45RO 10 population was small in adult PBL, while the CD45ROht population predominated (Fig . 4 A) . In two-color FAGS analysis, both Vbl + and Vb2 + T cells in umbilical cord blood lacked the CD45ROht phenotype. By 1 yr of life, CD45ROh' was expressed on -30% of the TCR-,y/b* cells. This percentage continued to rise between 1 and 18 yr of life to rti60% of the VS2* cells, suggesting that a significant proportion of these cells were previously activated (Fig . 4 B) . In contrast to Vb2* lymphocytes, Vbl+ lymphocytes remained <20% CD45RO h' even in adulthood (Fig . 4 B) . Moreover, no shift from CD45RO -to CD45RO`0 could be identified on V61-bearing T cells from children of increasing age (through age 18) (data not shown) . Thus, a striking differ- (A) CD45RO expression on PBL. CD45RO expression was analyzed on PBL at birth (cord blood), from a 6-yr-old child, and from an adult. The 6-yr-old child's profile was utilized to set cursors dividing the PBL into populations with negative (CD45RO-), low (CD45ROI°), or high (CD45ROh') expression of CD45RO determined by staining with mAb UCHLI and one-color FACS analysis . (B) CD45RO h' expression of Vbl-or V62-bearing T cells in peripheral blood. The percentage of Vbl`or VS2* -y/b T cells that express CD45ROh' was determined by two-color FACS analysis on CBL (triangles adjacent to they-axis) and on PBL (circles) and plotted versus age. Vbl* y/b cells (6TCS1*, open symbols) rarely express CD45ROh', while VS2* 'Y/b T cells (BB3*, closed symbols) showed an age-related increase in the percentage that express CD45ROh' . The percentage of Vbl* or VS2* cells that express CD45ROh' was determined in two-color FACS analysis by gating on the cells positive with the V&specific mAb and then determining the percentage of the gated cells that were in each of the three regions of UCHLI staining determined in Fig. 4 A. The percentage of cells expressing CD45ROh' was calculated using the formula: number of V61' or VS2* cells in the CD45ROh' region/total number of Vbl * or VS2* cells. The lines on the plot were generated usinga lowess smoother computer analysis (f = 0.5) (51) . ence existed in peripheral blood between the Vb2 + TCRy/b cells, which expanded in an age-related fashion and expressed s phenotype characteristic of "memory T cells"' and the Vbl + cells, which failed to expand in number or to express this memory phenotype. Acquisition of the memory phenotype on Vb2+ y/b T cells occurred during the age period in which the proportion of TCR-y/b cells bearing Vb2 in peripheral blood was increasing (compare Fig. 2 B, bottom, with Fig. 4 B) , suggesting that the increase in cell number might be related to activation and proliferation of these cells.
Individual Variation in TCR-y/S V Gene Repertoire. The observations noted above apply to the population of individuals in general. It has been reported that in most adults, >70% of the TCRy/b repertoire in peripheral blood can be accounted for by a single Vy2/VS2 chain pair (46) . The analysis here confirmed this generalization, but also identified a number of subjects who displayed a different pattern of expression of Vy and Vb genes in their peripheral blood. Four representative examples of healthy adults with differing TCRb V gene-defined phenotypes are shown (Fig . 5) . In peripheral blood from subject 1, Vb2 was expressed on 947o of the -Y/6 cells, with V61 expressed on nearly all the remaining TCRy/b cells. In this individual, Vb2 was paired predominantly with Vy2, while V61 was almost never paired with Vy2. This corresponds to the predominant phenotype previously reported by others (46) . In subject 2, Vb2 was expressed on 77% of the y/b T cells; the majority of the remaining y/b cells expressed Vbl. Like subject 1, Vb2 paired predominantly with Vy2; in contrast to subject 1, V61 paired with Vy2 on N60% of Vb1 + T cells. Subjects 3 and 4 differed strikingly from subjects 1 and 2 since VS2 expression was found on only 40 and 7% of the peripheral blood y/b T cells, respectively.
Correspondingly, in these latter subjects V61 expression predominated and was present on 41 of individuals, Vb2 usage predominated (subjects 1 and 2), while in the other cases, Vbl and VS2 were used about equally or V61 predominated (the least frequent occurrence) (subjects 3 and 4, respectively). Thus, while the majority ofTCR-'y/b cells in all subjects expressed either Vbl or VS2, the relative proportion of cells that expressed each of these TCR b chains varied . To confirm that an individual measurement in a person reflected a stable phenotype, four adults were examined on at least four occasions over a period of 18 mo. These analyses revealed a modest variation over time in the percentage of T cells expressing TCR-,y/4 but no significant variation in the relative expression and pairing of Vb1, Vb2, and Vy2. This suggested that the TCR-y/b repertoire in adults is relatively stable over a period of months to years.
The y/b Gene Repertoire Is Not Solely Determined by Inherited Factors. To determine if background genetic differences could account for the distinct , y/b V gene repertoires observed among individuals, family and twin studies were performed. In family 1 (Fig. 6 A) , both parents expressed a less common phenotype, in which Vb1 gene segment usage predominates over Vb2 gene segment expression (>50% V61, <30% Vb2) . However, all of the children displayed the common phenotype, expressing Vb2 on >70% of their TCR-y/b cells. Thus, none of the progeny displayed the parental y /b phenotype, despite the fact that each MHC haplotype carried by the parents was inherited by at least one of the children . In family 2 (Fig. 6 B) , one parent ex- To address whether other genetic elements besides those encoded in the MHC might determine the TCR-y/S V gene repertoire, seven sets of identical twins were evaluated (Fig. 7) . In four sets, both twins showed nearly identical'y/S V gene repertoires, expressing the common phenotype with VS2 on a majority of their .y/S T cells. However, several sets revealed divergent V gene usage. In both twin sets A and B, one individual utilized VS1 on -25% of the y/S T cells in peripheral blood, while the other individual utilized VS1 on <10% of they/S T cells. The twins also differed in VS2 usage, since one member of twin set A utilized VS2 on 85% of the y/S T cells, while the other individual utilized VS2 on 60% of the y/S T cells. Set B differed more dramatically in V82 usage; one individual expressed V62 on 30% of the y/S T cells, while the other individual expressed V62 on 93% of the y/S T cells. In each twin set, individual 1 has diabetes mellitus and individual 2 is healthy. However, it does not appear that the disease accounts for these differences in the expression of VS gene segments, as the VSI usage is high in the diabetic individual of one twin set, but in the nondiabetic individual of the other twin set. The different TCR-y/6 V gene repertoire in the peripheral blood of such identical twins supports the hypothesis that there are nongenetic influences that affect TCR'r/S variable chain expression on peripheral blood T cells .
Discussion
The repertoire of TCR-y/S variable gene segments expressed on lymphocytes in the thymus at birth was very similar to that expressed in peripheral blood (umbilical cord) at birth. However, with increasing age, the number of TCR-y/6-bearing T cells in peripheral blood increased during the first 6 yr of life and then fell slightly. This rise was accounted for by an increase in the number of V62 expressing TCR y/6 cells in peripheral blood, resulting in the previously described predominance of TCRy/6 cells bearing VS2 in adult PBL (27, 28) . However, the number of V61-bearing cells in peripheral blood did not change with age. Therefore, the ratio of V32/V61-bearing cells rose dramatically after birth until about age 6. During the period when the V62 number in PBL increased, no change in V&encoded gene segment expression was observed in thymus samples, including determinations performed on paired human thymus and peripheral blood samples from the same donor. The average ratio of V62/V61 as well as the proportion of T cells expressing TCR y/6 remained stable in the thymus at all ages studied, making it unlikely that a distinct thymic wave of cells bearing V62-encoded receptors occurred at the time of the observed increase in peripheral VS2' cells. On the other hand, a correlation existed between the rising number of VS2' cells and their high levels of expression of CD45RO. Taken together, the absence of a distinct VS2' postnatal thymic wave and the CD45RO phenotype supports the hypothesis that the age-related changes in peripheral blood TCRy/6 V gene repertoire are accounted for by extrathymic events, possibly antigen exposure . The peripheral population of VS2' T cells is polyclonal, since all of the genes analyzed from peripheral blood PCR (18/18 V62' VJC junctions) (47) or Southern blot analysis (four of four clones from each of two individuals) (29) showed distinct sequences or gene rearrangements . The fact that the V62 expansion (and preferential chain pairing) did not occur equally in individuals and that these differences could not be accounted for in an inherited fashion in families or identical twins suggested further that these individual variations might result from nongenetic environmental antigen or superantigen challenges. In other studies, expansion of T cells bearing specific VR gene segments have been noted in vitro after stimulation with staphylococcal toxins (48) . In addition, T cells expressing specific V6 gene segments have been shown to proliferate in response to mycobacterial antigens (12) . Thus, antigens like these might account for the expansion of V62-expressing y/6 T cells and their high levels of expression of CD45RO in peripheral blood. However, it is likely that a number of factors may play a role in determining the V6 repertoire . For example, selective homing could influence the V gene repertoire at each anatomical site as recent studies in both mice and man suggest that V gene usage varies at distinct anatomical sites. Similarly, TCR Vy-and V&encoded chain pairs may interact with distinct ligands in different tissues and be expanded on that basis. In this study, V61' T cells in the periphery expressed a naive phenotype. It is possible that these V61' cells may then migrate to localized sites where they are activated, as is thought to occur for lymphocytes in general (49) . Interestingly, in previous studies, VSl' lymphocytes have been shown to be present at twofold greater frequency than VS2' T cells in the human intestinal epithelium (50) . In contrast to normal individuals, in patients with coeliac disease, the proportion of IEL T cells expressing V61 is increased by more than fivefold, while the proportion of T cells expressing V62 is unchanged (50) . This suggests that V61' T cells might be stimulated preferentially in this location in contrast to the reciprocal expansion of VS2' cells that occurs in the peripheral blood pool as shown in this report . Information emerging from other studies has suggested an important role for develop-mentally regulated TCR gene rearrangements in determining the TCR-y/b repertoire (25) . The data presented here point to the importance ofextrathymic peripheral expansion of selected y/b subsets, in generating the adult TCR-,y/b repertoire.
Summary
The germline repertoire of variable genes for the TCR-,y/b is limited . This, together with the availability of several Vb-specific and a Cb-specific mAbs, has made it possible to assess differences in the TCRy/b repertoire in man . TCR-,y/b cells expressing particular V gene segments have been previously shown to be localized in different anatomical sites. In this study, analysis ofTCRy/b V gene segment usage performed on subjects from the time of birth through adulthood revealed striking age-related changes in the TCR-y/b repertoire in peripheral blood. Vbl + y/b T cells predominated in thymus as well as in peripheral blood at birth and then persisted as a relatively constant proportion of CD3 + PBL . However, Vb2 + y/b T cells that constitute a small proportion of the CD3 + cells in thymus and in peripheral blood at birth, then expand and account for the major population of y/b T cells in PBL in adults . No parallel postnatal expansion ofVb2+ cells in the thymus was observed, even when paired thymus-peripheral blood specimens were obtained on subjects between the ages of 3 d and 8 yr. The subset of Vb2 + lymphocytes that was expanded in peripheral blood expressed high levels of CD45RO suggesting prior activation ofthese cells, consistent with the possibility that their expansion might have resulted from exposure to foreign antigens or superantigens. In contrast, Vbl+ T cells in PBL showed no comparable increase in relative numbers and were either negative or expressed only low levels of CD45RO. Consistent with evidence for extrathymic peripheral expansion of selective TCR-,y/b subsets, no link between MHC haplotype and differences in the TCR-y/b V gene usage between individuals was apparent, and identical twins displayed TCR-,y/b variable gene segment phenotypes that were strikingly different from one another.
The elements that determine the TCRy/b repertoire in individuals are not known. It is possible that both thymic selection and extrathymic factors may influence the peripheral repertoire. Recently, TCRy/b+ lymphocytes have been shown to expand markedly in peripheral lymphoid tissues and infectious lesions in response to mycobacterial antigens (13, 15) , and a correlation between mycobacterial responses and TCR-,y/b V gene usage has been shown in mice (12) . The data presented here demonstrated peripheral age-related changes in the y/b repertoire and point to the importance of extrathymic expansion of specific y/b subsets in generating the human TCRy/b repertoire .
